Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomedine for Blunting Autonomic Response of Laryngoscopy and Intubation
NCT07480304Enrolling by invitation
- Sponsor
- Dow University of Health Sciences
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine (2 arms), sponsored by Dow University of Health Sciences. Primary endpoints: Heart Rate, Systolic Blood Pressure and 2 more. Started Dec 2025; status: enrolling by invitation.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07480304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07480304.